CDH1 and prostate carcinoma: Early evidence for the importance of cMErT with regards to metastatic outgrowths came from observations of equal or increased levels of E-cadherin expression in distant metastases compared to their matched primary breast and prostate cancer specimens [39,40,41,42,43].